Actively Recruiting
Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial
Led by Rush University Medical Center · Updated on 2025-03-26
100
Participants Needed
1
Research Sites
270 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized controlled trial (RCT) is designed to evaluate the new generation Exalt Model disposable duodenoscope compared to the reusable scope in terms of feasibility, ease of use, adverse events, number of crossover events, and infection rates.
CONDITIONS
Official Title
Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years or older with biliary or pancreatic duct disorder based on clinical symptoms and CT or magnetic resonance cholangiopancreatography
- Presence of native papilla
You will not qualify if you...
- Altered pancreaticobiliary anatomy
- Pregnancy
- Use of percutaneous transhepatic biliary drainage
- Prior history of ERCP
- Inability to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rush University Medical Center
Chicago, Illinois, United States, 60607
Actively Recruiting
Research Team
N
Neal A Mehta, MD
CONTACT
A
Amanda F Lin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here